Chang Y, Chi KY, Chen CM, Lin HM, et al. Association between SGLT2 inhibitor use and the risk of vertebral augmentation after initial osteoporotic vertebral fracture in patients with type 2 diabetes. Osteoporos Int 2026 Jan 8. doi: 10.1007/s00198-025-07839.
PMID: 41504956